Abstract:Continued, rapid development of antimicrobial resistance has become worldwide health crisis and a burden on the global economy. Decisive and comprehensive action is required to slow down the spread of antibiotic resistance, including increased investment in antibiotic discovery, sustainable policies that provide returns on investment for newly launched antibiotics, and public education to reduce the overusage of antibiotics, especially in livestock and agriculture. Without significant changes in the current antibiotic pipeline, we are in danger of entering a post-antibiotic era.In this Account, we summarize our recent efforts to develop next-generation streptogramin and lankacidin antibiotics that overcome bacterial resistance by means of modular chemical synthesis. First, we describe our highly modular, scalable route to four natural group A streptogramins antibiotics in 6–8 steps from seven simple chemical building blocks. We next describe the application of this route to the synthesis of a novel library of streptogramin antibiotics informed by in vitro and in vivo biological evaluation and high-resolution cryo-electron microscopy. One lead compound showed excellent inhibitory activity in vitro and in vivo against a longstanding streptogramin-resistance mechanism, virginiamycin acetyltransferase. Our results demonstrate that the combination of rational design and modular chemical synthesis can revitalize classes of antibiotics that are limited by naturally arising resistance mechanisms.Second, we recount our modular approaches toward lankacidin antibiotics. Lankacidins are a group of polyketide natural products with activity against several strains of Gram-positive bacteria but have not been deployed as therapeutics due to their chemical instability. We describe a route to several diastereomers of 2,18-seco-lankacidinol B in a linear sequence of ≤8 steps from simple building blocks, resulting in a revision of the C4 stereochemistry. We next detail our modular synthesis of several diastereoisomers of iso-lankacidinol that resulted in the structural reassignment of this natural product. These structural revisions raise interesting questions about the biosynthetic origin of lankacidins, all of which possessed uniform stereochemistry prior to these findings. Finally, we summarize the ability of several iso- and seco-lankacidins to inhibit the growth of bacteria and to inhibit translation in vitro, providing important insights into structure–function relationships for the class.This article has not yet been cited by other publications.

Overcoming Antibiotic Resistance Through Efficient and Scalable Total Synthesis

Total Synthesis of Three Families of Natural Antibiotics: Anthrabenzoxocinones, Fasamycins/Naphthacemycins, and Benastatins

Total synthesis of structurally diverse pleuromutilin antibiotics

Natural Products Resolve Antibiotic Resistance Crisis

Total Synthesis and Antimicrobial Evaluation of Natural Albomycins Against Clinical Pathogens

Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics

Optimization Of Globomycin Analogs As Novel Gram-Negative Antibiotics

Gram-scale Total Synthesis of Teixobactin Promoting Binding Mode Study and Discovery of More Potent Antibiotics

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Harnessing synthetic biology-based strategies for engineered biosynthesis of nucleoside natural products in actinobacteria

Total Synthesis of the Potent and Broad-Spectrum Antibiotics Amycolamicin and Kibdelomycin

Total Synthesis and Structural Reassignment of the Antitubercular Natural Product Evybactin

Discovery, Development and Syntheses of Tetracycline Antibiotics: Derivation from Natural Products and Application for Human Health

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Efficient Total Synthesis of Bioactive Natural Products: A Personal Record

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Industrial total synthesis of natural medicines

Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics

Semisynthesis: An Essential Tool for Antibiotics Drug Discovery

Total Synthesis of Complex Natural Products: Combination of Chemical Synthesis and Biosynthesis Strategies

Synthetic group A streptogramin antibiotics that overcome Vat resistance